EUCTR2016-005097-35-GB进行中（未招募）1 期
A randomised placebo-controlled trial of mifepristone and misoprostol versus misoprostol alone in the medical management of missed miscarriage - MifeMiso
适应症
相关药物
试验速览
- 阶段
- 1 期
- 状态
- 进行中（未招募）
- 入组人数
- 710
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional clinical trial of medicinal product
入排标准
- 性别
- Female
入选标准
- •1. Women diagnosed with missed miscarriage by pelvic ultrasound scan in the first 13+6 weeks of pregnancy.
- •2. Age 16 years and over.
- •3. Willing and able to give informed consent.
- •Are the trial subjects under 18? yes
- •Number of subjects for this age range: 20
- •F.1.2 Adults (18-64 years) yes
- •F.1.2.1 Number of subjects for this age range 690
- •F.1.3 Elderly (>=65 years) no
- •F.1.3.1 Number of subjects for this age range 0
排除标准
- •1. Women opting for alternative methods of miscarriage management (expectant or surgical)
- •2. Diagnosis of incomplete miscarriage.
- •3. Life threatening bleeding.
- •4. Contraindications to mifepristone or misoprostol use for example chronic adrenal failure, known hypersensitivity to either drug, haemorrhagic disorders and anticoagulant therapy, prosthetic heart valve or history of endocarditis, existing cardiovascular disease, severe asthma uncontrolled by therapy or inherited porphyria.
- •5. Participation in any other blinded, placebo-controlled trials of investigational medicinal products in pregnancy.
- •6. Previous participation in the MifeMiso trial
- •7. Woman not able to attend for day 6-7 ultrasound scan
研究者
相似试验
暂停
不适用
Medical methods for First trimester abortion upto 10weeksCTRI/2022/01/039355SDM College of medical sciences and hospital
已完成
不适用
Comparing efficacy of vaginal misoprostol administered at 6-8 hours with 24 hours administration after 200 mg of oral mifepristone for early medical abortionsISRCTN97410750Calthorpe Clinic (UK)1,200
进行中（未招募）
不适用
A Randomised Controlled Trial on Efficacy of mifepristone followed by 6-8 hours versus 24 hours vaginal misoprostol in Early Pregnancy Abortions (< 63 days gestations) - TIMES studyMedical termination of pregnancies before nine weeks of pregnancyEUCTR2009-010277-21-GBCalthorpe Clinic
进行中（未招募）
不适用
A randomised, placebo-controlled trial of the effect of pioglitazone on vascular endothelial function and novel biomarkers for macrovascular events in diabetics with established peripheral arterial disease - PAD and Pioglitazone StudyThe study involves patients with type 2 Diabetes and Peripheral Arterial Disease.The overall objective of the research proposal is to determine the occurrence of biomarkers that typify the metabolic syndrome in patients with peripheral vascular diseases.EUCTR2007-001800-20-GBniversity of Dundee
进行中（未招募）
不适用
A randomised, placebo controlled trial of the efficacy of the addition of spironolactone to modern antihypertensive treatment regimes in patients with resistant hypertension.EUCTR2006-004846-17-GBSheffield Teaching Hospitals NHS Foundation Trust